Clinical Trials Logo
  1. Home
  2. Familial Hypercholesterolemia
  3. NCT03900169
  4. Details
NCT03900169 Clinical Trial

Familial Hypercolerstremia as Risk Factor in Stemi Patient Who Underwent Ppci

Familial Hypercholesterolemia Clinical Trial

Official title:
Familial Hypercoleresremia as Risk Factor in Stemi Patient Underwent Ppci

Clinical Trial Details — Status: Active, not recruiting

Administrative data
NCT number NCT03900169
Other study ID # Familial hypercolerstremia
Secondary ID
Status Active, not recruiting
Phase
First received
Last updated
Start date November 1, 2020
Est. completion date November 1, 2021

Study information
Verified date June 2021
Source Assiut University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Famulial hypercolerstremia as risk factor

Description:

Familial hypercolerestremia ad risk factor in stemi patient who underwent Ppci

Recruitment information / eligibility
Status Active, not recruiting
Enrollment 2
Est. completion date November 1, 2021
Est. primary completion date August 1, 2021
Accepts healthy volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: -all patient that underwent Ppci Exclusion Criteria: - Previous ischemic patient - Patient with raised renal chemistry - Patient for CABG

Study Design

Related Conditions & MeSH terms

Intervention

Genetic:
• Genetic
Lipid profile

Locations
Country Name City State
Egypt Amira harby Assiut

Sponsors (1)
Lead Sponsor Collaborator
Assiut University

Country where clinical trial is conducted

Egypt, 

Outcome
Type Measure Description Time frame Safety issue
Primary Correlation between familial hypercolerstremia and prognosis of patients in PPCI Correlation between familial hypercolerstremia and prognosis of patients in PPCI One year
Primary Correlation between non familial hypercolerstremia and prognosis of patients in PPCI Correlation between non familial hypercolerstremia and prognosis of patients in PPCI One year
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05284513 - Collaborative Approach to Reach Everyone With Familial Hypercholesterolemia (CARE-FH) N/A
Enrolling by invitation NCT05271305 - Pilot Study for a National Screening for Familial Hypercholesterolemia
Completed NCT02750527 - Pediatric Population Screening for Type 1 Diabetes and Familial Hypercholesterolemia in Lower Saxony, Germany
Not yet recruiting NCT00924339 - Soy Food Intervention Trial N/A
Withdrawn NCT00751608 - Effect of APL180 on Endothelial Function in Familial Hypercholesterolemia Patients Phase 2
Terminated NCT00079846 - Implitapide in Patients With Homozygous Familial Hypercholesterolemia (HoFH) on Maximal Concurrent Lipid-Lowering Therapy Phase 2
Completed NCT02624869 - Safety, Tolerability and Efficacy of Evolocumab (AMG 145) in Children With Inherited Elevated Low-density Lipoprotein Cholesterol (Familial Hypercholesterolemia) Phase 3
Recruiting NCT05758779 - The Danish Familial Hypercholesterolemia Organized Coronary Screening Trial N/A
Enrolling by invitation NCT04929457 - Evaluation of a Digiphysical Screening Method to Identify and Diagnose Familial Hypercholesterolemia
Not yet recruiting NCT04455581 - A Study to Determine the Safety, Tolerability, and Efficacy of SHR-1209 in Patients With Familial Hypercholesterolemia Phase 2
Recruiting NCT04101149 - Genetic Causes of Familial Hypercholesterolemia
Completed NCT00943306 - Long Term, Follow-on Study of Lomitapide in Patients With Homozygous Familial Hypercholesterolemia Phase 3
Completed NCT02462655 - Effects of LDL Apheresis System on the Expression of Genes Involved in Lipoprotein Metabolism and Inflammation in Homozygotes for Familial Hypercholesterolemia N/A
Terminated NCT00079859 - Implitapide in Patients With Heterozygous Familial Hypercholesterolemia (HeFH) on Maximal Concurrent Lipid-Lowering Therapy Phase 2
Recruiting NCT05066932 - Advanced Lipoproptein Profiling and Cardiovascular Risk Stratification in Familial Hypercholesterolemia
Not yet recruiting NCT04958629 - A Prospective Cohort Study on Familial Hypercholesterolemia in Health Examination Population
Completed NCT02709850 - Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IONIS ANGPTL3-LRx in Healthy Volunteers With Elevated Triglycerides and Participants With Familial Hypercholesterolemia Phase 1
Active, not recruiting NCT03832985 - Pediatric Reporting of Adult-Onset Genomic Results Early Phase 1
Terminated NCT02013713 - French Observatory of Familial Hypercholesterolemia in Cardiology
Recruiting NCT02009345 - Familial Hypercholesterolemia Canada / Hypercholesterolemie Familiale Canada